Larimar Therapeutics' CTI-1601 offers hope for Friedreich's ataxia patients, with promising trial results. Check out why LRMR ...

Panelists discuss how the differential diagnosis for Friedreich's Ataxia involves distinguishing it from other ataxias, the ...

Most people haven’t heard of the condition, but Friedreich’s ataxia is getting more attention because of a new treatment and ...

A Friedreich ataxia specialist discusses how the typical clinical presentation of Friedreich's Ataxia includes early onset with symptoms such as ataxia and sensory loss, while also examining the ...

An unvaccinated, 3-year-old Morgan mare in Jefferson County, New York, recently tested positive for Eastern equine ...

Friedreich’s ataxia is a progressive neuromuscular disease that causes uncoordinated movement, muscle weakness, balance problems, impaired speech, and frequently, heart abnormalities.

Voyager Therapeutics (VYGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

One horse in Utah County, Utah, recently tested positive for West Nile virus (WNV). The horse’s current status is unknown.

Genetic analysis beyond the causative variants, and independent of the core clinical symptoms (pyramidal signs versus ataxia), might offer a more pertinent way to approach phenotypic variability.

In order to improve the quality of life of patients with the Ataxia disease, the biotechnological and pharmaceutical industry ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.

Some investors might want to combine high yield with growth-like exposure. Check out two picks with attractive yields, while ...